Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hsin-Pei Chung"'
Autor:
Yi-Hao Chiang, Ching-Ting Lien, Wen-Hao Su, Tsung-Yu Yen, Yu-Jen Chen, Yuen-Liang Lai, Ken-Hong Lim, Kun-Yao Dai, Hsin-Pei Chung, Chia-Yen Hung, Yi-Shing Leu
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background Clinical evidence for the rapidity and effectiveness of fentanyl buccal soluble film (FBSF) in reducing pain intensity of breakthrough cancer pain (BTcP) remains inadequate. This study aimed to evaluate the efficacy of FBSF propor
Externí odkaz:
https://doaj.org/article/990397aded314904b25b731d8795187e
Autor:
Kuan-Chih Kuo, Chao-Hsien Chen, Chieh-Jen Wang, Jou-Chun Wu, Hsin-Pei Chung, Yen-Ting Chen, Yen-Hsiang Tang, Wen-Kuei Chang, Chang-Yi Lin, Chien-Liang Wu
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The successful management of patients infected with coronavirus disease 2019 (COVID-19) with inhaled ciclesonide has been reported, however few studies have investigated its application among hospitalized patients. Methods This re
Externí odkaz:
https://doaj.org/article/d808ffa56777404abaa2aaa7757e8106
Autor:
Hsin-Pei Chung, Yen-Hsiang Tang, Chun-Yen Chen, Chao-Hsien Chen, Wen-Kuei Chang, Kuan-Chih Kuo, Yen-Ting Chen, Jou-Chun Wu, Chang-Yi Lin, Chieh-Jen Wang
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundThe aim of our study was to externally validate the predictive capability of five developed coronavirus disease 2019 (COVID-19)-specific prognostic tools, including the COVID-19 Spanish Society of Infectious Diseases and Clinical Microbiolo
Externí odkaz:
https://doaj.org/article/f0e55cc4ac344d91aab280ded3cc34f3
Autor:
Wen-Jui Wu, Sheng-Hsiung Yang, Hsin-Pei Chung, Chia-Te Yen, Yen-Ting Chen, Wei-Chin Chang, Jian Su, Hsuan-Yu Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The prevalence and impact of epidermal growth factor receptor (EGFR) Q787Q polymorphism on the treatment of lung adenocarcinoma remains unclear. We retrospectively analyzed patients with stage IV lung adenocarcinoma to evaluate the prevalence of the
Externí odkaz:
https://doaj.org/article/af497f8e80c345ef90c2bbd97bde633f
Autor:
Ping-Tsung Yu, Chao-Hsien Chen, Chieh-Jen Wang, Kuan-Chih Kuo, Jou-Chun Wu, Hsin-Pei Chung, Yen-Ting Chen, Yen-Hsiang Tang, Wen-Kuei Chang, Chang-Yi Lin, Chien-Liang Wu
Publikováno v:
Expert Review of Respiratory Medicine. 17:319-328
Autor:
Chih Bin Lin, Chao Hua Chiu, Kang Yun Lee, Wen Hui Ku, Yen-Ting Lin, Yu-Feng Wei, Shang Yin Wu, Jian Su, Mei Hsuan Lee, Jen Yu Hung, Jin-Yuan Shih, Chi Lu Chiang, Hsin Pei Chung, Wu Chou Su, Yen Han Tseng, Tsai Shin Chiang
Publikováno v:
European Journal of Cancer. 156:1-11
Introduction Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) crizotinib, ceritinib, alectinib, brigatinib, and lorlatinib are approved for advanced non–small-cell lung cancer (NSCLC) with ALK rearrangement. However, the mechanism
Publikováno v:
Therapeutic Hypothermia and Temperature Management. 10:153-158
Targeted temperature management (TTM) is widely used for postcardiac arrest management of patients with out-of-hospital cardiac arrest. However, the use of TTM for patients with in-hospital cardiac arrest (IHCA) is controversial. The aim of this stud
Autor:
Hsin-Pei Chung, Kuo-Lun Wu, Chang-Yi Lin, Yen-Hsiang Tang, Chao-Hsien Chen, Jou-Chun Wu, Yen-Ting Chen, Kuan-Chih Kuo, Wen-Kuei Chang
Publikováno v:
International Journal of Gerontology; Jul2022, Vol. 16 Issue 3, p207-212, 6p
Autor:
Yen-Hsiang Tang, Shu-Fen Hsu, Hsin-Pei Chung, Chao-Hsien Chen, Wen-Kuei Chang, Kuan-Chih Kuo, Yen-Ting Chen, Jou-Chun Wu, Chang-Yi Lin, Chieh-Jen Wang
Publikováno v:
International Journal of Gerontology; Jul2022, Vol. 16 Issue 3, p191-195, 5p
Autor:
Chao-Hsien Chen, Ching-Lung Liu, Yu-Chia Lai, Chin-Ching Lin, Mei-Chuan Pai, Kuan-Chih Kuo, Hsin-Pei Chung, Chang-Yi Lin
Publikováno v:
International Journal of Gerontology; Oct2021, Vol. 15 Issue 4, p345-349, 5p